These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15877738)

  • 1. Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
    Yoshimi A; Niemeyer CM; Bohmer V; Duffner U; Strahm B; Kreyenberg H; Dilloo D; Zintl F; Claviez A; Wössmann W; Kremens B; Holter W; Niethammer D; Beck JF; Kontny U; Nöllke P; Klingebiel T; Bader P
    Br J Haematol; 2005 May; 129(4):542-9. PubMed ID: 15877738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.
    Bader P; Niemeyer C; Willasch A; Kreyenberg H; Strahm B; Kremens B; Gruhn B; Dilloo D; Vormoor J; Lang P; Niethammer D; Klingebiel T; Beck JF
    Br J Haematol; 2005 Mar; 128(5):649-58. PubMed ID: 15725087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
    Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
    Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
    Bader P; Kreyenberg H; Hoelle W; Dueckers G; Handgretinger R; Lang P; Kremens B; Dilloo D; Sykora KW; Schrappe M; Niemeyer C; Von Stackelberg A; Gruhn B; Henze G; Greil J; Niethammer D; Dietz K; Beck JF; Klingebiel T
    J Clin Oncol; 2004 May; 22(9):1696-705. PubMed ID: 15117992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study.
    Choi SJ; Lee KH; Lee JH; Kim S; Chung HJ; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Aug; 26(3):327-32. PubMed ID: 10967574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism].
    Beck JF; Klingebiel T; Kreyenberg H; Schaudt A; Wölle W; Niethammer D; Bader P
    Klin Padiatr; 2002; 214(4):201-5. PubMed ID: 12165902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Inagaki J; Fukano R; Nishikawa T; Nakashima K; Sawa D; Ito N; Okamura J
    Pediatr Blood Cancer; 2013 Jan; 60(1):116-20. PubMed ID: 22847790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of chimerism in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation].
    Furukawa T; Hashimoto S; Inano K; Yamazaki F; Takeda H; Kakihara T; Yano T; Abe T; Higuchi W; Toba K; Takahashi M; Koike T; Aizawa Y
    Rinsho Ketsueki; 2001 Jun; 42(6):488-95. PubMed ID: 11505528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.
    Bader P; Kreyenberg H; Hoelle W; Dueckers G; Kremens B; Dilloo D; Sykora KW; Niemeyer C; Reinhardt D; Vormoor J; Gruhn B; Lang P; Greil J; Handgretinger R; Niethammer D; Klingebiel T; Beck JF
    Bone Marrow Transplant; 2004 Apr; 33(8):815-21. PubMed ID: 14990984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse.
    Serrano J; Román J; Herrera C; Castillejo JA; Navarro JA; Reina ML; González MG; Rodriguez MC; Pascual A; Sánchez J; Torres A
    Bone Marrow Transplant; 1999 Mar; 23(5):475-82. PubMed ID: 10100562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic approach to molecular quantitative determination of mixed chimaerism following allogeneic bone marrow transplantation: an analysis of its applicability in a group of patients with severe aplastic anaemia.
    Hassan R; Bonamino MH; Braggio E; Lobo AM; Seuánez HN; Tabak DG; Zalcberg IR
    Eur J Haematol; 2004 Sep; 73(3):156-61. PubMed ID: 15287911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved.
    Massenkeil G; Nagy M; Lawang M; Rosen O; Genvresse I; Geserick G; Dörken B; Arnold R
    Bone Marrow Transplant; 2003 Mar; 31(5):339-45. PubMed ID: 12634724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
    Yoshimi A; Bader P; Matthes-Martin S; Starý J; Sedlacek P; Duffner U; Klingebiel T; Dilloo D; Holter W; Zintl F; Kremens B; Sykora KW; Urban C; Hasle H; Korthof E; Révész T; Fischer A; Nöllke P; Locatelli F; Niemeyer CM;
    Leukemia; 2005 Jun; 19(6):971-7. PubMed ID: 15800672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.
    Huisman C; de Weger RA; de Vries L; Tilanus MG; Verdonck LF
    Bone Marrow Transplant; 2007 Mar; 39(5):285-91. PubMed ID: 17262061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia.
    Faraci M; Micalizzi C; Lanino E; Scuderi F; Morreale G; Dini G; Cappelli B; Dallorso S
    Pediatr Transplant; 2005 Dec; 9(6):797-800. PubMed ID: 16269054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation.
    Lutz C; Massenkeil G; Nagy M; Neuburger S; Tamm I; Rosen O; Dörken B; Arnold R
    Bone Marrow Transplant; 2008 May; 41(9):805-12. PubMed ID: 18195682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.